Jushi (JUSHF) versus Its Peers Critical Survey

Jushi (OTCMKTS:JUSHF) is one of 54 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Jushi to related companies based on the strength of its risk, valuation, dividends, earnings, profitability, analyst recommendations and institutional ownership.

Volatility and Risk

Jushi has a beta of -0.16, meaning that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.37, meaning that their average stock price is 37% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Jushi and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	2	0	0	2.00
Jushi Competitors	203	531	843	66	2.47

As a group, “Medicinals & botanicals” companies have a potential upside of 70.25%. Given Jushi’s peers stronger consensus rating and higher probable upside, analysts clearly believe Jushi has less favorable growth aspects than its peers.

Earnings & Valuation

This table compares Jushi and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jushi	$269.45 million	-$65.10 million	-1.93
Jushi Competitors	$314.89 million	-$158.29 million	-10.00

Jushi’s peers have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 14.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.0% of Jushi shares are owned by insiders. Comparatively, 21.5% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Jushi and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-24.16%	-320.66%	-10.31%
Jushi Competitors	-45.95%	-62.18%	-9.03%

Summary

Jushi peers beat Jushi on 9 of the 13 factors compared.

Jushi Company Profile

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.